Charles Russell Speechlys has an experienced Private Equity team that boasts an indepth knowledge of advising on all aspects of private equity transactions including MBOs, MBIs, buy-and-builds, secondary buy-outs and exits.
We act for private equity houses, management teams and investee companies and have the capability to act on all stages of the life cycle from fund formation, to investment, to ultimate exit. Members of the team have experience of working on the full range of private equity transactions from small cap to some of the largest deals.
We also act for venture and growth capital investors, be they business angels, high net worth investors, venture capital or venture debt funders or providers of growth capital. We also advise early stage and high growth companies seeking investment including SEIS, EIS and VCT qualifying investments, rounds of venture capital funding and growth capital investment. We act for entrepreneurs as they seek to establish and develop their businesses.
A unique aspect of our offering is our strong private client presence, which gives us access to family offices, high and ultra-high net worth individuals as well as business owners. This presents opportunities from a private equity perspective, including in relation to assisting deal origination and ability to refer transactions.
We also have a full service offering in all areas necessary to support transactional work including strong Banking & Finance and Corporate Tax teams with experience of advising on all aspects of debt financing and tax related matters relevant to private equity transactions. In addition, we have teams in the full suite of specialist areas including intellectual property, competition, employment, pensions, real estate, commercial dispute resolution and restructuring.
This year the team have been shortlisted for:
- Law Firm of the Year – Deal Structuring award at the unquote British Private Equity Awards;
- Private Equity Team of the Year at the British Legal Awards;
- Regional/ Specialist Legal Adviser of the Year Advisory Award at the Real Deals Private Equity Awards; and
- Service Provider of the Year at the Investor Allstars Awards
News & Insights
Charles Russell Speechlys advises Emergex Vaccines on $11m fundraising
Emergex is a UK-based biotechnology company and pioneers of developing synthetic ‘set point’ vaccines .
Charles Russell Speechlys advises Purdy & Figg Ltd on equity fundraising round
Purdy & Figg Ltd is a family owned manufacturer of natural, premium cleaning products.
Charles Russell Speechlys advises Shore Capital as nomad and broker on Helios Underwriting plc £20m fundraising
Helios is an AIM-listed investment company offering investors growth and returns from exposure to Lloyd’s.